Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in ...

BD (NYSE: BDX) announced today that it plans to invest more than $35 million in U.S.-based prefilled flush syringe ...

Swiss entrepreneur Willy Michel, who founded Ypsomed, controls TecMed. His son, Simon Michel, is CEO of Ypsomed. Included in ...

Trividia Health announced today that it launched its new TRUEplus five-bevel insulin pen needle line in the UK.

Sava Technologies announced today that it raised $19 million in a Series A financing round to support its wearable biosensor ...

Dexcom (Nadsaq:DXCM) today reported second-quarter financial results that came in ahead of the consensus forecast.

Trinity Biotech (Nasdaq:TRIB) announced today that it unveiled its new flagship continuous glucose monitor (CGM) biosensor ...

Tidepool announced that it began rolling out its new cloud-to-cloud integration with the Abbott (NYSE:ABT) FreeStyle Libre ...

Stelo, the first FDA-cleared over-the-counter glucose biosensor, joins the G7 continuous glucose monitor (CGM) in offering ...

What has changed in the last year as diabetes technology developers continue to innovate and advance their offerings?

Beta Bionics (Nasdaq:BBNX) shares rose after hours today on raised 2025 guidance and second-quarter results that beat the ...

This notice comes just weeks after an initial warning about potential underinfusion with all Novum IQ large-volume pumps.